zie protocol
ID
Source
Brief title
Condition
- Allergic conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
zie protocol
Secondary outcome
zie protocol
Background summary
zie protocol
Study objective
zie protocol
Study design
zie protocol
Intervention
zie protocol
Study burden and risks
zie protocol
Postbus 30.001
Groningen 9700 RB
NL
Postbus 30.001
Groningen 9700 RB
NL
Listed location countries
Age
Inclusion criteria
- A positive history of a systemic response grade II/III/IVa after vespid sting
- Specific serum IgE > 0.7 kU/
- Positive intracutaneous skin test for vespid venom ( at <= 1 µg/ml)
Exclusion criteria
- A positive history of a systemic response grade IVb according to Müller after a vespid sting
- Age under 18 years or above 65 years
- Severe cardiopulmonary disease (clinical evidence of congestive heart failure, coronary disease or severe hypertension)
- Insufficiently controlled asthma, especially if FEV1 is 70% of predicted.
- Conditions that influence the immune system (immune deficiencies, malignancy, auto-immune diseases)
- Severe kidney failure
- Interfering medication with the outcome or recovery from a systemic reaction (β-blockers and immunosuppressive drugs)
- Allergy to auxiliary matter in Pharmalgen® Vespula spp.
- Pregnancy
- Mastocytosis
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| EudraCT | EUCTR2013-001102-29-NL |
| CCMO | NL43093.042.13 |